Research
What research is being done for pancreatic cancer treatments and screenings today? The next life-saving treatment for the disease may be on the horizon. These articles highlight the latest in pancreatic cancer research.
360 Articles
mRNA Vaccine Trial Expands to Numerous Locations
The mRNA vaccine trial spearheaded by Dr. Vinod Balachandran has opened in more locations in the US and around the world.
More Effective Treatment for Metastatic Pancreatic Cancer
A worldwide clinical trial is testing a new drug combined with standard treatment, for patients with metastatic pancreatic cancer.
Pancreatic Cancer Research Updates from ASCO 2024
Learn about the latest developments in pancreatic cancer research into immunotherapy and chemotherapy from the ASCO 2024 meeting.
Can SBRT Become More Effective?
Radiation oncologist Dr. Todd Aguilera is looking for ways to make SBRT a more effective treatment for pancreatic cancer.
Study Reveals Molecular Differences in Young-Onset Pancreatic Cancer
There has been a notable increase in cases of young onset pancreatic cancer. Dr. Jashodeep Datta and team are exploring why this is happening.
A New Triple Combination for Tumors with BRCA1/2 or PALB2 Mutations
A clinical trial is comparing a two-drug combination with a three-drug combination to see which works better for genetic mutations.
Using AI to Create a Better Test to Predict Pancreatic Cancer Progression
Dr. Dan Theodorescu is using AI to isolate more effective biomarkers than the CA 19-9 test to track pancreatic cancer progression.
2024 AACR Meeting Update
Some of the highlights of the latest pancreatic cancer research from the 2024 AACR meeting include the mRNA vaccine, and a liquid biopsy.
Using Ultrasound to Enhance the Effectiveness of Chemotherapy
A clinical trial combines ultrasound with a microbubble contrast agent to make chemotherapy more effective.
Felix 2.0 Builds Upon Artificial Intelligence Earlier Detection Successes
Can artificial intelligence help find pancreatic cancer sooner? Dr. Elliot Fishman thinks so, and has been working to make it happen.
Slowing the Growth of One Type of Advanced Neuroendocrine Tumor
Dr. Kelsey Klute explains the advantages of the radiopharmaceutical lutetium Lu 177 dotatate treatment for certain neuroendocrine tumors.
Leveraging Nanoparticle Technology for Paclitaxel Delivery in Pancreatic Cancer Patients
Dr. Allyson Ocean explains why nanoparticle delivery technology for getting paclitaxel to the tumor could be advantageous for patients.
For Families at Risk, Remote Education May Be Key in Improving Genetic Testing Uptake
What’s the best way to educate families at risk for pancreatic cancer about genetic testing? Dr. Sapna Syngal discusses the results of the GENERATE study.
Platform Trial Increases Efficiency in Studying Immunotherapy
Dr. Elizabeth Jaffee is betting that three types of immunotherapy will rev up the immune system and make chemotherapy more effective in a platform trial.
Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer
Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.